Cabergoline 1mg tablets

Země: Velká Británie

Jazyk: angličtina

Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)

Koupit nyní

Stáhnout Informace pro uživatele (PIL)
30-11--0001

Aktivní složka:

Cabergoline

Dostupné s:

Dowelhurst Ltd

ATC kód:

N04BC06

INN (Mezinárodní Name):

Cabergoline

Dávkování:

1mg

Léková forma:

Oral tablet

Podání:

Oral

Třída:

No Controlled Drug Status

Druh předpisu:

Valid as a prescribable product

Přehled produktů:

BNF: 04090100

Informace pro uživatele

                                CABERGOLINE 1MG TABLETS/
CABERGOLINE 2MG TABLETS
(cabergoline)
Your medicine is known by either of the above names, but will be
referred to
as Cabergoline throughout the following:
PATIENT INFORMATION LEAFLET
WHAT IS IN THIS LEAFLET
1) What Cabergoline is and what it is used for
2) What you need to know before you take Cabergoline
3) How to take Cabergoline
4) Possible side effects
5) How to store Cabergoline
6) Contents of the pack and other information
1) WHAT CABERGOLINE IS AND WHAT IT IS USED FOR
Cabergoline belongs to a group of medicines known as dopamine
agonists.
Cabergoline acts in a similar way to a chemical present in the nervous
system called dopamine. Patients with Parkinson’s disease do not
have
enough of this important chemical.
Cabergoline is used to treat Parkinson’s disease. It can be used
either
taken alone or in combination with levodopa, as second choice
following
non-ergot derived therapies.
Treatment under a specialist is required.
2) WHAT YOU NEED TO KNOW BEFORE YOU TAKE CABERGOLINE
DO NOT TAKE CABERGOLINE IF YOU
•
are allergic to cabergoline, other ergot alkaloids (e.g.
bromocriptine), or to
any of the other ingredients of this medicine (listed in section 6)
•
have swelling of the hands and feet and a high blood pressure during
pregnancy (preeclampsia, eclampsia)
•
have uncontrolled high blood pressure
•
have ever been diagnosed in the past with problems described as
fibrotic
reactions affecting the lungs, back of the abdomen and kidneys or
heart
•
will be treated with Cabergoline for a long period and have or had
fibrotic
reactions (scar tissue) affecting your heart.
Before you are given Cabergoline your doctor will arrange for you to
have
tests to assess the condition of your heart. Your doctor will continue
to
monitor your medical condition while taking Cabergoline.
WARNINGS AND PRECAUTIONS
If you have any of the following health problems you must inform your
doctor before taking Cabergoline as the medicinal product may be
unsuitable for you:
•
cardiovascular disease

                                
                                Přečtěte si celý dokument
                                
                            

Vyhledávejte upozornění související s tímto produktem